363 related articles for article (PubMed ID: 24692538)
1. Molecular stress-inducing compounds increase osteoclast formation in a heat shock factor 1 protein-dependent manner.
Chai RC; Kouspou MM; Lang BJ; Nguyen CH; van der Kraan AG; Vieusseux JL; Lim RC; Gillespie MT; Benjamin IJ; Quinn JM; Price JT
J Biol Chem; 2014 May; 289(19):13602-14. PubMed ID: 24692538
[TBL] [Abstract][Full Text] [Related]
2. HSP90 inhibitors enhance differentiation and MITF (microphthalmia transcription factor) activity in osteoclast progenitors.
van der Kraan AG; Chai RC; Singh PP; Lang BJ; Xu J; Gillespie MT; Price JT; Quinn JM
Biochem J; 2013 Apr; 451(2):235-44. PubMed ID: 23379601
[TBL] [Abstract][Full Text] [Related]
3. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
Price JT; Quinn JM; Sims NA; Vieusseux J; Waldeck K; Docherty SE; Myers D; Nakamura A; Waltham MC; Gillespie MT; Thompson EW
Cancer Res; 2005 Jun; 65(11):4929-38. PubMed ID: 15930315
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of heat shock protein 90 rescues glucocorticoid-induced bone loss through enhancing bone formation.
Chen H; Xing J; Hu X; Chen L; Lv H; Xu C; Hong D; Wu X
J Steroid Biochem Mol Biol; 2017 Jul; 171():236-246. PubMed ID: 28408351
[TBL] [Abstract][Full Text] [Related]
5. Heat shock factor 1 confers resistance to Hsp90 inhibitors through p62/SQSTM1 expression and promotion of autophagic flux.
Samarasinghe B; Wales CT; Taylor FR; Jacobs AT
Biochem Pharmacol; 2014 Feb; 87(3):445-55. PubMed ID: 24291777
[TBL] [Abstract][Full Text] [Related]
6. HSP90 inhibitor 17-AAG selectively eradicates lymphoma stem cells.
Newman B; Liu Y; Lee HF; Sun D; Wang Y
Cancer Res; 2012 Sep; 72(17):4551-61. PubMed ID: 22751135
[TBL] [Abstract][Full Text] [Related]
7. Activation of heat shock factor 1 plays a role in pyrrolidine dithiocarbamate-mediated expression of the co-chaperone BAG3.
Song S; Kole S; Precht P; Pazin MJ; Bernier M
Int J Biochem Cell Biol; 2010 Nov; 42(11):1856-63. PubMed ID: 20692357
[TBL] [Abstract][Full Text] [Related]
8. Heat shock transcription factor 1-activating compounds suppress polyglutamine-induced neurodegeneration through induction of multiple molecular chaperones.
Fujikake N; Nagai Y; Popiel HA; Okamoto Y; Yamaguchi M; Toda T
J Biol Chem; 2008 Sep; 283(38):26188-97. PubMed ID: 18632670
[TBL] [Abstract][Full Text] [Related]
9. Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.
Bagatell R; Paine-Murrieta GD; Taylor CW; Pulcini EJ; Akinaga S; Benjamin IJ; Whitesell L
Clin Cancer Res; 2000 Aug; 6(8):3312-8. PubMed ID: 10955818
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of heat shock protein (molecular weight 90 kDa) attenuates proinflammatory cytokines and prevents lipopolysaccharide-induced liver injury in mice.
Ambade A; Catalano D; Lim A; Mandrekar P
Hepatology; 2012 May; 55(5):1585-95. PubMed ID: 22105779
[TBL] [Abstract][Full Text] [Related]
11. HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.
Schulz R; Streller F; Scheel AH; Rüschoff J; Reinert MC; Dobbelstein M; Marchenko ND; Moll UM
Cell Death Dis; 2014 Jan; 5(1):e980. PubMed ID: 24384723
[TBL] [Abstract][Full Text] [Related]
12. Induction of multiple heat shock proteins and neuroprotection in a primary culture model of familial amyotrophic lateral sclerosis.
Batulan Z; Taylor DM; Aarons RJ; Minotti S; Doroudchi MM; Nalbantoglu J; Durham HD
Neurobiol Dis; 2006 Nov; 24(2):213-25. PubMed ID: 16950627
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of N-terminal ATPase on HSP90 attenuates colitis through enhanced Treg function.
Collins CB; Aherne CM; Yeckes A; Pound K; Eltzschig HK; Jedlicka P; de Zoeten EF
Mucosal Immunol; 2013 Sep; 6(5):960-71. PubMed ID: 23321985
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin is a stress responsive gene regulated by HSF1 in response to geldanamycin.
Dhanani KCH; Samson WJ; Edkins AL
Sci Rep; 2017 Dec; 7(1):17617. PubMed ID: 29247221
[TBL] [Abstract][Full Text] [Related]
15. Possible involvement of HSP90-HSF1 multichaperone complex in impairment of HSP72 induction in the failing heart following myocardial infarction in rats.
Marunouchi T; Araki M; Murata M; Takagi N; Tanonaka K
J Pharmacol Sci; 2013; 123(4):336-46. PubMed ID: 24285117
[TBL] [Abstract][Full Text] [Related]
16. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
[TBL] [Abstract][Full Text] [Related]
17. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
18. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1.
Zou J; Guo Y; Guettouche T; Smith DF; Voellmy R
Cell; 1998 Aug; 94(4):471-80. PubMed ID: 9727490
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of 90-kD heat shock protein potentiates the cytotoxicity of chemotherapeutic agents in human glioma cells.
Ohba S; Hirose Y; Yoshida K; Yazaki T; Kawase T
J Neurosurg; 2010 Jan; 112(1):33-42. PubMed ID: 19408974
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Hsf1 activity by novobiocin and geldanamycin.
Conde R; Belak ZR; Nair M; O'Carroll RF; Ovsenek N
Biochem Cell Biol; 2009 Dec; 87(6):845-51. PubMed ID: 19935870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]